Clinical Trials Browser

Unknown × Cholangiocarcinoma × Injections × Clear all

NCT04454905 2023-04-19

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma